Inicio › Esteatosis hepática › Virginia › Richmond
Ensayos clínicos de Esteatosis hepática en Richmond, VA
12 estudios para Esteatosis hepática buscan participantes en centros de Richmond y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
ReclutandoFase 3
- 89bio Clinical Study Site, Richmond
- 89bio Clinical Study Site, Richmond
- 89bio Clinical Study Site, Richmond
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
ReclutandoFase 3
- 89bio Clinical Study Site, Richmond
- 89bio Clinical Study Site, Richmond
- 89bio Clinical Study Site, Richmond
Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
ReclutandoFase 2
- Virginia Commonwealth University, Richmond
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
ReclutandoFase 2
- Richmond Veterans Administration Medical Center, Richmond
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
ReclutandoFase 3
- Richmond Veterans Affairs Medical Center (Richmond VA Medical Center), Richmond
- Virginia Commonwealth University (VCU) Medical Center, Richmond
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
ReclutandoFase 3
- Akero Clinical Study Site, Richmond
- Akero Clinical Study Site, Richmond
- Akero Clinical Study Site, Richmond
- y 1 más
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
ReclutandoFase 2
- GI Alliance Richmond, Richmond
- GI Select Health Research, Richmond
A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
ReclutandoFase 2
- GSK Investigational Site, Richmond
- GSK Investigational Site, Richmond
A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
ReclutandoFase 2
- GSK Investigational Site, Richmond
Randomized Double Blinded Placebo-Controlled w/Semaglutide to Prevent Weight Gain After Liver Transplant
ReclutandoFase 2
- Virginia Commonwealth University, Richmond
Non-Invasive Quantification of Liver Health in NASH (N-QUAN)
Reclutando
- Virginia Common wealth University, Richmond
Predicting Outcomes in Nonalcoholic Steatohepatitis With Advanced Fibrosis
ReclutandoEstudio observacional
- Virginia Commonwealth University, Richmond
Más información sobre Esteatosis hepática en MedlinePlus
Ensayos de Esteatosis hepática en otras ciudades
- San Antonio, TX17 estudios
- New York City, NY16 estudios
- Miami, FL16 estudios
- San Diego, CA14 estudios
- Austin, TX13 estudios
- Houston, TX13 estudios
- Chandler, AZ10 estudios
- Tucson, AZ10 estudios
- St. Louis, MO9 estudios
- Orlando, FL9 estudios
- Hialeah, FL9 estudios
- Dallas, TX9 estudios
Otros estudios en Richmond
- Cáncer de seno26 estudios
- Cáncer de pulmón de células no pequeñas25 estudios
- Cáncer de próstata19 estudios
- Fallo cardíaco16 estudios
- Cáncer de pulmón14 estudios
- Enfermedad cardiovascular13 estudios
- Cáncer del colon y del recto13 estudios
- Leucemia mielógena aguda12 estudios
- Cáncer metastásico12 estudios
- Carcinoma de células escamosas de cabeza y cuello12 estudios
- Melanoma11 estudios
- Obesidad11 estudios
De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.